fda shortage glp-1 Proposes Ban on Bulk Compounding for Semaglutide, Tirzepatide, and Liraglutide New GLP-1 Pill Foundayo (Orforglipron)

Glucagon-like peptide-1 (GLP-1) is a hormone involved in glucose homeostasis and satiety regulation

Its released in the gut after you eat and plays a powerful role in: Slowing the emptying of your stomach (helping you feel fuller, longer) Enhancing insulin production and lowering blood sugar Reducing appetite and sugar cravings Supporting

But as key patents begin approaching expiry over the coming years, a new phase is unfolding the generics and biosimilar race

The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.

Not for human or animal consumption

The supercharged formula is clinically proven to deliver luminosity in minutes